Although Aβ therapies are still under clinical trials, certain drug classes, such as cholinesterase inhibitors (galantamine, rivastigmine, donepezil, and tacrine), are used to treat mild-to-moderate or late-stage AD in patients. This evidence concerns the gene BCHE and Alzheimer disease.